
RF-2 grants safe conduct to indigenous leader, understanding that cultivation is part of his identity, spirituality, and indigenous medicine

Cannabis is a plant with a long history of use, dating back thousands of years. Originally used for medicinal purposes, cannabis was later banned in many countries due to its psychoactive effects. However, in recent years, cannabis has been increasingly accepted as an effective and safe medicinal substance.

A scientific review highlights the lack of robust evidence on medical cannabis and reinforces the need for more rigorous and balanced research in the field

Decision from the 2nd Federal Court of Guarulhos determines that authorities do not seize oil, cannabis flowers, and vaporizer used in medical treatment by Argentine patient.

Delegates highlight the importance of bringing pharmaceutical cultivation to the country and reducing costs in the API chain

For Fritz Eduardo Kasbaum the scientific ecosystem is ready to expand, but still depends on changes in national regulation

Badger G® variety promises to boost the pharmaceutical sector and facilitate monitoring with red leaves and high CBG content

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Check out the confirmed names: Beatriz Marti Emygdio, Filipe Campos, Tarso Araujo, and João Paulo Silvério Perfeito will be among the specialists participating in the event in São Paulo

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers

2025 Yearbook shows treatment expansion, prescribers scenario, and an approximate revenue of R$ 1 billion

Cannabis

Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

Still in the study phase, cannabidiol shows potential to relieve symptoms such as pain, swelling, and insomnia related to varicose veins

Discover what the male flower in cannabis is, why it appears, and how to prevent it from compromising your harvest